CCHIT Approves Pre-Market EHR | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

CCHIT Approves Pre-Market EHR

June 24, 2009
by root
| Reprints

San Jose, Calif.-based Axolotl Corp.’s Elysium 9, has been approved as a pre-market conditional Certification Commission for Healthcare Information Technology (CCHIT) Certified 08 Ambulatory electronic health record, the company says.

Pre-market conditionally certified EHRs, Axolotl says, are new products that become fully certified once their operational use at a physician office site has been verified. The company says it intends to maintain Elysium 9’s certification to meet the Chicago-based organization’s required standards and certification criteria that will ensure physicians are well positioned to achieve and demonstrate meaningful use as referenced in the HITECH act. According to the company, the new software version is freely available, at no additional license cost, to its 25,000 licensed physicians, many of whom contributed to its development.

According to the company, a CCHIT Certified 08 Ambulatory EHR ensures additional electronic prescribing features, enhanced ability to view X-rays and other diagnostic images, and the better management of patient consents and authorizations.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).